Drugs

2022.01.18_Final GSR 19(E)_Amendment in rules 19B, 19C,19D &19E of MDR 2017.pdfDCC_Guidelines_Spurious_Drugs.pdfDrugs-and-Cosmetics-Amandment-Act-No.-26-of-2008-1.pdfDrugs Rules, 1945 wef 01-08-2023.pdfDR_G.S.R. 654(E) dt_24.08.2022_Parallel submission in Form 28-D Rule 75 ammendment.pdfDR_G.S.R. 839(E) dt_29.11.2021_Amendment of rule 24 and 24A , 1945 to omit provisions for issuing duplicate copy of the Im.pdfG.-S.-R.-186-E-dtd-6.3.2019-Drugs-and-Cosmetics-Fifth-Amendment-Rules-2019-1.pdfG.-S.-R.-205-E-dtd-8.3.2019-Drugs-and-Cosmetics-Sixth-Amendment-Rules-2019-1.pdfG.-S.-R.-223-E-dtd-18.3.2019-Drugs-and-Cosmetics-Eighth-Amendment-Rules-2019-Reg.-Testing-Lab-Form-39-A.pdfG.-S.-R.-227-E-dtd-19.3.2019-New-Drugs-and-Clinical-Trials-Rules-2019-1.pdfG.-S.-R.-231-E-dtd-20.3.2019-Drugs-and-Cosmetics-Ninth-Amendment-Rules-2019-1.pdfG.-S.-R.-317-E-dtd-18.04.2019-Drugs-and-Cosmetics-Tenth-Amendment-Rules-2019-1.pdfG.-S.-R.-499-E-dtd-17.07.2019-Drugs-and-Cosmetics-Eleventh-Amendment-Rules-2019-1.pdfG.S.R-289-dt-15-04-2015-Drugs-and-Cosmetics-Third-Amendment-Rules-2015-Advertisement-of-the-drugs.pdfG.S.R-502E-dt-22-07-2021-Draft-in-Rule-127-SChedule-Q-to-insert-IS-4707-BIS.pdfG.S.R-1380E-10-11-17-Homeopathy-Experience-person-1.pdfG.S.R.-103E-dated-02.02.2017-Drugs-and-Cosmetics-4th-Amendment-Rules-2017-Rule-36A-Import-of-drugs-by-charitable-hospital-free-of-cost.pdfG.S.R.-No.-827E-dt.-06-11-19-Draft-Notification-Sch-K.pdfGDR-618E-dt-07-09-2021-Draft-Drugs-Amendment-Rules-2021-Rule-24-regarding-duplicate-copy-of-license.pdfGDR-628E-dt-13-09-2021-Draft-Drugs-Amendment-Rules-2021-Sr.-No.-38-of-Schedule-K.pdfGSR-19-E-dtd-10.1.2019-–-Drugs-and-Cosmetics-Amendment-Rules-2019-Rule-84AB-information-to-be-uploaded-on-Sugam-Portal.pdfGSR-30E-dt-20-01-2022-for-exemption-of-sale-license-of-antiseptics-under-schedule-K-of-the-Drugs-Rules-1945.pdfGSR-45E-dt-21-01-2010-Drugs-imported-by-Sea-in-India-Drugs-and-Cosmetics-1st-Amendment-Rules-2010.pdfGSR-45E-dt-24-01-2011-Vaccines-and-Recombinant-are-new-drugs-Drugs-and-Cosmetics-1st-Amendment-Rules-2011.pdfGSR-75E-dt-01-02-2022-Draft-notification-Inclusion-of-Acitretin-in-Sch-H-of-Drugs-Rules-1945.pdfGSR-101-E-Dt.-11-02-20-Drugs-and-Cosmetics-Amendment-Rules-2020-Marketers.pdfGSR-140E-26-02-2021-DC-Rules-1945-Schedule-K-Substitution-of-Anaganwadi-workers-and-Community-Health-Officers-at-Ayushman-Bharat.pdfGSR-144-E-dated17-02-2017-regulation-on-Oseltamivir-phosphate-zanamivir.pdfGSR-158E-dt-24-02-2022-Inclusion-of-Allura-Red-colour-in-rule-127-of-the-Drugs-Rules-1945.pdfGSR-160E-dt-16-03-2006-Schedule-H-536-drugs-Drugs-and-Cosmetics-2nd-Amendment-Rules-2006.pdfGSR-166-E-11-03-20-Blood-Bank-Blood-Centre.pdfGSR-197E-dt-17-03-3021-Drfat-notification-for-Ayurvedic-Sidha-Unani-drugs.pdfGSR-202E-dt-22-03-2021-Drugs-and-Cosmetics-Amendment-Rules-2021-Testing-of-Indian-Medicine-and-Homoeopathic-medicines.pdfGSR-219-E-dt-26-03-2020-Hydroxychloroquine-is-Schedule-H-1-drug-now.pdfGSR-219E-dt.-26-03-2020-Sec-26-B-Hydroxychloroquine-now-a-schedule-H1-drug.pdfGSR-222-E-dt-13-03-2018-Rule-96-Labelling-of-drugs.pdfGSR-227E-dt-29-03-2022-To-include-colour-of-disinfectants-in-rule-127-of-Drugs-Rules-1945.pdfGSR-249E-dt-04-04-2002-Funstions-of-Laboratories-regarding-Blood-grouping-reagents-etc..pdfGSR-250E-dt-15-03-2017-Enzymes-Hormones-Bacterial-and-Viral-vaccines-inserted-to-be-tested-by-Central-Research-Institute-Kasauli.pdfGSR-255E-dt-07-04-2021-Exclusion-of-FDC-of-Tamsulosin-and-Deflazacort-from-banned-list-of-drugs.pdfGSR-258E-dt-07-04-2021-Inclusion-of-Tapentadol-in-schedule-H1-of-the-Drugs-Rules-1945.pdfGSR-311-Drugs-and-Cosmetics-Rules-3rd-ammandment-2002.pdfGSR-327-dt-03-04-2017-BA-BE-studies-Drugs-and-Cosmetics-Ninth-Amendment-Rules-2017.pdfGSR-341E-dt.-24-04-2023-Amendment-in-Rule-153-Drugs-Amendment-Rules-2023.pdfGSR-357-E-Dt-18-05-2022-Inclusion-of-Acitretin-in-Sch-H-of-Drugs-Rules-1945.pdfGSR-382E-dt-23-05-2022-Draft-Notification-New-Drug-Incertion-in-Rule-75.pdfGSR-383E-dt-23-05-2022-Draft-Notification-Proviso-to-Sr.-No-39-in-Sch-K-for-Liquid-Antiseptics-in-Drugs-Rules.pdfGSR-393-E-dt-25-05-2022-Draft-notification-Exemption-under-Schedule-K-of-the-Drugs-Rules-1945-for-OTC-drugs.pdfGSR-408E-dt-26-04-2018-Labelling-of-drugs-Caution-or-warning-under-Schedule-G-H-H1-and-X-as-per-Rule-97-Drugs-and-Cosmetics-Fifth-amendment-Rule-2018.pdfGSR-411E-dt-27.04.2018-Manufacture-Prohibition-of-Oxytocin-with-conditions-under-Section-26A-of-DC-Act.pdfGSR-448E-dt-14-06-2022-Amendment-in-rule-96-for-mandating-Bar-code-or-QR-code-on-the-label-of-top-300-brand-in-Drugs-Rules.pdfGSR-471E-dt-04-08-2006-Schedule-K-Drugs-and-Cosmetics-Amendment-Rules-2006.pdfGSR-473E-dt-02-07-2021-Draft-Drugs-and-Cosmetics-Amendment-Rules-2021-Homoeopathy.pdfGSR-502E-Dt-30-06-2022-Schedule-K-Incertion-in-Sr.-No.-39-Drugs-Fifth-Amendment-Rules-2022.pdfGSR-521E-dt-01-06-2018-DRugs-and-Cosmetics-Sixth-Amendment-Rules-2018-insertion-in-Rule-36.pdfGSR-558E-Dt-17-07-2015-Diclofenac-Injection-for-Human-use-in-single-pack-unit-only.pdfGSR-570-E-dated-07-08-2014-regarding-drug-formulation-permission-in-proper-or-generic-name-only.pdfGSR-611E-dt-01-09-2021-Draft-notification-for-Rule-43A-Drugs-Amndment-Rules-2021.pdfGSR-623E-dt-10-08-2022-To-include-colour-of-disinfectants-in-rule-127-of-Drugs-Rules-1945.pdfGSR-651E-dt-09-09-2009-Central-Drugs-Testing-Laboratory-Drugs-and-Cosmetics-5th-Amendment-Rules-2009.pdfGSR-654E-dt-24-08-2022-Parallel-submission-of-manufacturing-marketing-approvals-in-Form-28-D-Drug-Seventh-Amendment-Rules-2022.pdfGSR-656E-dt-20-10-2020-Draft-notification-regarding-addition-of-Tapentadol-in-Schedule-H1.pdfGSR-669E-dt-23-09-2021-Draft-Rules-import-of-new-Homoeopathic-Medicines-Drugs-and-Coemtics-Amendment-Rules-2021.pdfGSR-686E-Dt-25-09-2023-Draft-Notification-Inclusion-of-Oseltamivir-and-Zanamivir-in-Schedule-H1-Drugs-Rules-1945.pdfGSR-687E-dt-25-09-2023-draft-notification-packsize-Schedule-P-Drug-Rules-1945.pdfGSR-716E-dt-01-10-2021-Drugs-4th-Amendment-Rules-2021-For-manufacturing-of-Ayurvedic-Sidha-and-Unani-Drugs.pdfGSR-762E-dt-27-10-2021-Sec-10-of-DC-Act-To-allow-import-of-Oxytocin-API-for-manufacture-of-formulation-for-export-purpose-only.pdfGSR-766E-dt-27-10-2021-Form-29-Deemed-Approval-after-7-days-Rule-90-Drugs-5th-Amendment-Rules-2021.pdfGSR-767E-dt-27-10-2021-Draft-to-amend-rule-2-to-substitute-cell-or-stem-cell-derived-product-under-NDCTR-2019.pdfGSR-794E-dt-21-08-2018-Mfg-of-Oxytocin-Formulation-by-Public-Sector-26A-of-DC-Act.pdfGSR-795-E-dt-21-08-2018-Oxytocin-Inclusion-in-Sch-H1-omittion-from-Sch-H.pdfGSR-823E-dt-17-11-2022-Schedule-H2-Drugs-Rules-Eighth-Amendment-2022.pdfGSR-828-E-dated-06-11-2019-regarding-submission-of-Form-51-by-the-manufacturer-for-marketing-the-drug-under-brand-name.pdfGSR-839E-dt-29-11-2021-Amendment-of-rule-24-and-24A-to-omit-provisions-for-issuing-duplicate-copy-of-the-Import-licence-and-Registration-certificate-Drug-6th-Amendment-Rules-2021.pdfGSR-840E-dt-29-11-2021-Draft-Amendment-of-rule-127-for-adding-allura-red-in-coal-tar-colour-List-of-colours-permitted-to-be-used-in-drugs-Drug-Amendment-Rules-2021.pdfGSR-848E-dt-09-12-2021-Final-Notification-of-ICD-Tihi-M.P.-in-Rule-43A-of-Drugs-Rules.pdfGSR-899E-dt-27-12-2011-Blood-Bank-Drugs-and-Cosmetics-3rd-Amendment-Rules-2011.pdfGSR-917E-dt-22-12-2009-Schedule-K-Homoeopathic-Hair-Oil-Drugs-and-Cosmetics-7th-Amendment-Rules-2009.pdfGSR-999E-dt.-05-10-2018-Draft-for-Amendment-in-Schedule-M.pdfGSR-1161-E-dt-03-12-2019-Amendment-in-Rule-96-Labelling-of-drugs.pdfGSR-1186-E-dt-07-12-2018-Rule-1272-Approved-or-permitted-color-in-Gelatine-capsule.pdfGSR-4271E-dt-26-11-2019-12-Govt-Analyst-notified-for-the-whole-of-India.pdfGSR-No-220-E-dt-26-03-2020-regarding-door-step-delivery-of-medicines.pdfGSR-No.-20E-dt-18-01-2022-Quick-Response-code-on-API-Drugs-Amendment-Rules-2022.pdfGSR-No.-410E-dt-02-06-2023-Notification-for-Gangavaram-port-Drugs-Amendment-Rules-2023.pdfGSR-No.-443E-dt-25-06-2021-Environment-Protection-Second-Amendment-Rule-2021.pdfGSR-No.-524-dt-02-08-2021-DRaft-New-Drugs-and-Clinical-TrialAmendment-Rules-2021.pdfGSR-No.-533E-dt-03-08-2021-Draft-Drug-Amendment-Rules-2021-Regarding-Form-29 (1).pdfGSR-No.-533E-dt-03-08-2021-Draft-Drug-Amendment-Rules-2021-Regarding-Form-29.pdfGSR-No.-588E-Dt-30-08-2013-Schedule-H1-Drugs-DC-fourth-Amendment-Rules-2013.pdfGSR-No.-675-E-dt-06-09-1994-Draft-Drugs-and-Cosmetics-Amendment-Rules-1945-regarding-Schedule-R.pdfGSR166E Blood-Blood components-june 2020.pdfGSR 227 E New Drugs -Clinical Trial Rules 2018.pdfGuidance document VeterinaryBiological.pdfMarketing Declairation Rule 71, 76-Form 51 GSR 828E.pdfMinistry-of-Health-Dt-08-07-2022-Draft-of-New-Drugs-Medical-Devices-and-Cosmetics-Bill-2022.pdfNotification Marketer responsibility firm gsr101E) Responsibility.pdfRetention GSR 2017.pdfS.-O.-1500-E-dt.-02-04-2019-Organ-preservative-solution-as-drug-1.pdfS.-O.-2237-E-dt.-01-06-2018-Designated-Central-Medical-Device-Testing-Laboratory-2 (1).pdfFDC warning indications for childrens Dec 2023Revised Schedule M Dec-2023.pdfIndian Market Product not to export.jpeg